Genetic knockdown of USP20 via shRNA significantly induced apoptosis and suppressed proliferation in AML cells <i>in vitro</i>, while <i>in vivo</i> depletion of USP20 attenuated leukemia development and improved overall survival. The gene discussed is USP20; the disease is acute myeloid leukemia.